going from tirzepatide to retatrutide vs Compared going from tirzepatide to retatrutide

What should I tell an anesthesiologist or procedural team about my GLP-1 medication

doi: 10.1016/j.clnesp.2022.01.014

The needle is so thin that nerve endings often do not register its passage

GLP-1(936) depletes docked granules pool The fact that GLP-1(936) remains glucagonostatic regardless of whether glucagon secretion is triggered by low glucose alone, membrane depolarisation or receptor-induced elevation of cAMP suggests it may act late in the secretory process, possibly at the level of exocytosis itself

Do not start, stop, or change any medication without speaking to your healthcare provider

Excited to keep going. -User, Google Review Overall sentiment: Positive, with praise for pricing and support but concerns about first shipment speed